Medical evidence follows a defined structure, and knowing it makes health coverage much easier to read.
Trial phases
Safety, then dosing, then efficacy against comparison, then post-market monitoring.
Which answer different questions.
Randomisation and blinding
Assigning treatment by chance and concealing who received what.
Which removes several sources of bias.
Endpoints
What the trial measured.
Which is frequently a proxy rather than the outcome that matters.
Sample size
Determining what effects could have been detected.
Why the comparison group matters most
Most conditions improve on their own for some people, and most treatments produce expectation effects.
Which means a study without a comparison group cannot distinguish the treatment from either.
The single most useful question about any health claim is what it was compared against, and a surprising amount of coverage does not say.
Surrogate endpoints
Measuring a marker rather than the outcome that matters.
Which is faster and sometimes misleading.
Relative and absolute risk
A large proportional change on a small baseline.
Which is how modest effects are made to sound dramatic.
Pre-registration
Declaring what will be measured before the trial runs.
Which prevents selective reporting.
Where to look
Trial registries and systematic reviews rather than press releases.
How to read a health headline
Ask what was studied, in whom, compared against what, and how large the effect was in absolute terms.
Which four questions dispose of most misleading coverage.
A finding in laboratory cells or in mice is not a finding in people, and a substantial proportion of health reporting does not make that distinction clearly.
Observational against interventional
Watching what happens against assigning treatment.
Which is the difference between association and evidence of cause.
Confounding
Other factors explaining an apparent relationship.
Which observational studies attempt to adjust for imperfectly.
Systematic reviews
Combining all available evidence with defined methods.
Which sits above any single study.
A general note
This is about reading research and is not medical advice.
Why single studies rarely settle anything
Any individual trial has a specific population, a specific comparison, a specific dose and a specific outcome measure.
Which means it answers a narrow question, and generalising beyond it is where most misinterpretation happens.
Systematic reviews exist precisely because the reliable answer emerges from the accumulated body of evidence rather than from whichever study was published this week.
Publication bias
Positive results more likely to appear.
Which distorts the visible literature.
Industry funding
Sponsorship associated with more favourable findings.
Which is documented and does not mean any individual study is wrong.
Regulatory review
Agencies assessing full data rather than published summaries.
A general note
This is about interpreting evidence rather than any specific treatment.
The pattern that recurs
Across almost all of these systems, the same three things turn out to be true. The behaviour that looks irrational from outside is optimising for something the observer cannot see. The cost that seems unexplained is usually concentrated in one specific stage of the process. And the information that would resolve the confusion is generally published somewhere and read by nobody.
That last point is the most useful. Regulators, operators and industry bodies publish an enormous amount of explanatory material that answers exactly the questions people complain about not being able to get answers to. It is dry, it is not promoted, and it is free.
A note on sources
Where regulation is involved, national regulators publish the actual rules and they are generally clearer than press coverage of them. Where an industry is involved, trade publications aimed at people working in it are considerably more informative than consumer coverage.
Practices described here vary substantially between countries, and anything with legal, financial or medical consequences warrants checking against the rules that apply where you are.
What to do with any of this
Very little of it changes a decision on its own. What it changes is the ability to ask a better question: of a company, of a service, of a regulator, or of yourself before assuming that something went wrong.
Why it is worth knowing how these things work
Most of the systems that shape ordinary life are invisible by design. Nobody explains why a parcel took an odd route, why a price changed between two searches, or why a wait extended.
The absence of explanation is rarely deliberate concealment. It is that the people running these systems are solving their own problems, and the reasoning behind their decisions is obvious to them and completely opaque from outside. Understanding the mechanism does not always change what you can do about it, and it does remove a category of frustration that comes from assuming something is arbitrary when it is not.
Where to read further
Trade publications written for people working in an industry are consistently the most informative public source on how it operates, and most of them are freely readable.
They assume knowledge that general coverage explains and skip the framing that general coverage adds, which makes them harder to start with and considerably more useful once you do.